As of Aug 21
| -0.17 / -0.40%|
The 20 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 42.00, with a high estimate of 48.00 and a low estimate of 34.00. The median estimate represents a -0.38% decrease from the last price of 42.16.
The current consensus among 20 polled investment analysts is to Buy stock in Pfizer Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.